Response to Letter Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)"

Circulation. 2016 May 17;133(20):e662. doi: 10.1161/CIRCULATIONAHA.116.022321.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Disease Management
  • Familial Primary Pulmonary Hypertension*
  • Humans
  • Hypertension, Pulmonary
  • Registries
  • Survival Rate
  • Warfarin*

Substances

  • Warfarin